Many roads lead to oncogene-induced senescence
S Courtois-Cox1, S L Jones, K Cichowski
1Genetics Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 2115, USA.
Abstract:
Oncogene-induced senescence is a mechanism of tumor suppression that restricts the progression of benign tumors. Important advances have been made toward elucidating the mechanisms that regulate this response; however, there is presently no unified model that integrates all current findings. DNA damage, replicative stress, reactive oxygen species, heterochromatin formation and negative feedback signaling networks have all been proposed to play an integral role in promoting senescence in response to various oncogenic insults. In all cases, these signals have been shown to function through Rb and p53, but utilize different intermediaries. Thus, it appears that senescence is not triggered by a single, linear series of events, but instead is regulated by a complex signaling network. Accordingly, multiple proteins may cooperate to establish a senescence response, but the limiting signal(s) may be dictated by the initiating genetic alteration and/or tissue type. This review will focus on integrating current models and will highlight data that provide new insight into the signals that function to suppress human tumor development.
Insights
Oncogene-induced senescence, a tumor suppression mechanism, involves complex signaling networks rather than a single pathway. Understanding these intricate signals is key to developing new human tumor development therapies.
Area of Science:
- Cellular Biology
- Oncology
- Molecular Biology
Background:
- Oncogene-induced senescence is a crucial tumor suppression mechanism.
- Current models lack a unified framework integrating diverse senescence-inducing signals.
- Key proposed triggers include DNA damage, replicative stress, and oxidative stress.
Purpose of the Study:
- To integrate current models of oncogene-induced senescence.
- To provide new insights into signals suppressing human tumor development.
- To highlight the complexity of senescence regulatory networks.
Main Methods:
- Review of existing literature on oncogene-induced senescence.
- Analysis of signaling pathways involving Rb and p53.
- Integration of data on various senescence-promoting insults.
Main Results:
- Senescence is regulated by a complex signaling network, not a single linear pathway.
- Multiple proteins cooperate to establish senescence, with limiting signals dependent on the initiating event and tissue type.
- Signals converge through Rb and p53 but use distinct intermediaries.
Conclusions:
- A unified model for oncogene-induced senescence is needed.
- Understanding the complex network is vital for targeting human tumor development.
- Further research into specific signaling intermediaries will advance cancer suppression strategies.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Replicative Cell Senescence
Replicative Cell Senescence
Cancers Originate from Somatic Mutations in a Single Cell


